December 9, 2025
SOHO Insider Loretta Nastoupil, MD

Loretta Nastoupil, MD

  • by
  • November 25, 2025
  • 0 Comments
  • Less than a minute
  • 351 Views
  • 2 weeks ago

Share This Post:

Related Post

Leukemia, Lymphoma, News

Pirtobrutinib significantly improves PFS in patients with treatment-naïve CLL/SLL

December 9, 2025
Multiple Myeloma, News

“Promising” early-phase results seen with KLN-1010, an off-the-shelf in

December 9, 2025
Time to phase 3 symbol. Concept word Phase 1 2 3 on wooden block. Businessman hand. Beautiful grey table grey background. Business planning and time to phase 3 concept. Copy space.
Multiple Myeloma, News

Teclistamab plus daratumumab improves survival compared with SOC triplet

December 9, 2025
Time to phase 3 symbol. Concept word Phase 1 2 3 on wooden block. Businessman hand. Beautiful grey table grey background. Business planning and time to phase 3 concept. Copy space.
ASH 2025, Leukemia, Chronic Lymphocytic Leukemia, Meetings / Conferences, News

Phase 3 study finds fixed-duration treatment non-inferior to continuous

December 7, 2025
ASH 2025, Lymphoma, News

Extended MorningSun study results show ‘promising’ survival with subcutaneous

December 6, 2025
pen check
ASH 2025, Multiple Myeloma, News

Pre-apheresis lenalidomide improves T-cell fitness in patients with myeloma

December 6, 2025